Company intelligence / Profile preview

Lab-to-Medi CRO

Yangsan-si, Gyeongsangnam-do, South Korealabtomedicro.com ↗
Ownership
Private
Development stage
Other
01

Overview

Lab-to-Medi CRO is a South Korean contract research organization (CRO) and biotechnology company founded in 2020 by Dr. Bo Sun Joo. The company provides comprehensive clinical trial services, regulatory affairs consulting, and data management for pharmaceuticals, health functional foods, cosmetics, and medical devices. In addition to its CRO services, Lab-to-Medi CRO conducts active research and development in biomaterials, specifically focusing on computer-aided design of visfatin-derived angiogenic peptides (such as Vis-1 and Vis-2) for applications in wound healing, skin regeneration, and ovarian function improvement.

Therapeutic areas
Women's HealthDermatology
Modalities
PeptidesBiologic
Industry
Contract Research Organization
02

Drug pipeline

1 asset

visfatin A-domain peptide

Preclinical
03

Partnerships

P&K Skin Clinical Research CenterThe Korea Institute for Public Sperm BankPusan National UniversityDong-A University

Beyond the preview

Go deeper on Lab-to-Medi CRO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lab-to-Medi CRO.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call